Effects of the use of semaglutide as a pharmacological option for weight loss in adults with BMI > 25 Kg/m²: a scoping review. Research, Society and Development, [S. l.], v. 12, n. 4, p. e9012440955, 2023. DOI: 10.33448/rsd-v12i4.40955. Disponível em: https://rsdjournal.org/rsd/article/view/40955. Acesso em: 5 dec. 2025.